Godavari Biorefineries’ European Patent for Anti-Cancer Molecule Now Validated in Key Jurisdictions

Godavari Biorefineries Limited announced that its European patent for a novel anti-cancer molecule has been validated in Spain, the United Kingdom, and as a Unitary Patent covering multiple EU member states. The patented molecule has demonstrated efficacy against both cancer cells and cancer stem cells, marking a promising advance toward more targeted and effective cancer therapies. It has shown potential in the treatment of various cancers, including breast and prostate cancer, with encouraging efficacy and safety profiles in preclinical animal studies. The molecule is currently in Phase 1a clinical trials to assess safety in human patients with advanced solid tumors as well as in healthy volunteers. This patent validation marks a significant milestone in the company's journey toward advancing original, high-quality scientific research, reflecting the dedication of its teams and its aspiration to contribute meaningfully to global knowledge and innovation.